glp-1 drugs and cancer may have a beneficial effect across many types of Dr. - The GLP-1 cancer

Eli Lilly and Company closely follows with tirzepatide, which offers dual-action benefits for both diabetes and obesity, further strengthening its competitive edge

Metabolic-bariatric surgery reduces pancreatic cancer risk: a meta-analysis of over 3.7 million adults, independent of type 2 diabetes status

The primary mechanism is AMPK activation

Specifically, vildagliptin forms a transient imidate intermediate with DPP4, stabilized by interactions with Tyr547 and Tyr631 in the S1 subsite

Cuthbertson DJ, Irwin A, Gardner CJ et al (2012) Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists